homosteroids - CISMeF

Preferred Label : homosteroids;

MeSH definition : Steroids whose structure has been expanded by the addition of one or more carbon atoms to the ring skeleton in any of the four rings.;

Is substance : O;

Détails

Origin ID

D006718;

UMLS CUI

C0019901;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- homosteroids [MeSH concept]
Related MeSH Supplementary Concept(s)
- 12-deacetoxyscalaradial [MeSH Supplementary Concept]
- 16-acetoxy-17-acetoxymethyl-11,17-dihydroxy-D-homoandrosta-1,4-diene-3,17-dione [MeSH Supplementary Concept]
- 17-hydroxy-7-methyl-D-homoestra-4,16-dien-3-one [MeSH Supplementary Concept]
- 17-methyl-16-phenyl-17-(2-fluorophenyl)acetoxyhomoandrost-4,6-diene-3,17a-dione [MeSH Supplementary Concept]
- 17-methyl-16-phenyl-17-(3-fluorophenyl)acetoxyhomoandrost-4,6-diene-3,17a-dione [MeSH Supplementary Concept]
- 17-methyl-16-phenyl-17-phenylacetoxyhomoandrost-4,6-diene-3,17a-dione [MeSH Supplementary Concept]
- 3-hydroxy-6-oxo-7-oxa-B-homo-5-cholestane [MeSH Supplementary Concept]
- 3-hydroxy-7-oxo-6-oxa-B-homo-5-cholestane [MeSH Supplementary Concept]
- 4,6-diaza-A,B-dihomo-24-ethylcholest-3,7-dione [MeSH Supplementary Concept]
- 4,6-diaza-A,B-dihomocholest-3,7-dione [MeSH Supplementary Concept]
- 6-hydroxy-D-homo-8-isoestrone methyl ether [MeSH Supplementary Concept]
- 6-oxabenz(3,4)-D-homoestra-1,3,5(10),8,14-pentaen-17-one [MeSH Supplementary Concept]
- 7a,17a-diaza-7,17-dioxo-B,D-dihomo-5-androsten-3-yl 4-N,N-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 9-fluoro-11,16,17-trihydroxy-17-hydroxymethyl-D-homoandrosta-1,4-diene-3,17-dione [MeSH Supplementary Concept]
- APR19 compound [MeSH Supplementary Concept]
- APR6 compound [MeSH Supplementary Concept]
- dendalone 3-hydroxybutyrate [MeSH Supplementary Concept]
- nakiterpiosin [MeSH Supplementary Concept]
- nakiterpiosinone [MeSH Supplementary Concept]
- pingbeimine C [MeSH Supplementary Concept]
- scalaradial [MeSH Supplementary Concept]
- sphaerophyside SD [MeSH Supplementary Concept]
- yibeinoside B [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients